Cargando…
Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
BACKGROUND: Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adjuvant treatment of malignancies to eradicate or control residual disease. Cytoki...
Autores principales: | Wang, Danhong, Zhang, Bin, Gao, Haiyan, Ding, Guoliang, Wu, Qiong, Zhang, Jinchao, Liao, Li, Chen, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997215/ https://www.ncbi.nlm.nih.gov/pubmed/24720900 http://dx.doi.org/10.1186/1471-2407-14-251 |
Ejemplares similares
-
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020) -
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017) -
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021) -
Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013) -
Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
por: Xie, Yunqing, et al.
Publicado: (2017)